trioxifene has been researched along with Breast Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Green, LR; Newboult, E; Valcaccia, B; Wakeling, AE | 1 |
| Boldt, DH; Estrada, P; Osborne, CK | 1 |
| Arafah, B; Manni, A; Pearson, OH | 1 |
| Blaszczak, LC; Crowell, TA; Goettel, ME; Jones, CD; Mabry, TE; Ruenitz, PC; Srivatsan, V; Suarez, T | 1 |
| Carbone, PP; Falkson, G; Falkson, H; Moss, S; Pretorius, FJ; Pruitt, B; Ramirez, G; Rose, DP; Tormey, DC; Witte, RS | 1 |
| Blumenschein, GR; Buzdar, AU; Hortobagyi, GN; Lee, RW | 1 |
2 trial(s) available for trioxifene and Breast Neoplasms
| Article | Year |
|---|---|
Trioxifene mesylate (LY 133314): a new antiestrogen which inhibits growth hormone secretion in the rat.
Topics: Aged; Animals; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Estrogen Antagonists; Female; Glucagon; Gonadotropins, Pituitary; Growth Hormone; Humans; Middle Aged; Pyrrolidines; Rats | 1980 |
Trioxifene mesylate in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Male; Middle Aged; Pyrrolidines; Receptors, Estrogen; Tamoxifen | 1986 |
4 other study(ies) available for trioxifene and Breast Neoplasms
| Article | Year |
|---|---|
Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells.
Topics: Animals; Breast Neoplasms; Cell Line; Estrogen Antagonists; Female; Humans; Mammary Neoplasms, Experimental; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Rats; Receptors, Estrogen; Tamoxifen; Thiophenes; Uterus | 1984 |
Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
Topics: Breast Neoplasms; Cell Cycle; Cell Line; Culture Media; Estradiol; Estrogen Antagonists; Female; Humans; Kinetics; Nafoxidine; Pyrrolidines; Tamoxifen | 1984 |
Antiestrogens. 3. Estrogen receptor affinities and antiproliferative effects in MCF-7 cells of phenolic analogues of trioxifene, [3,4-dihydro-2-(4- methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]- phenyl]methanone.
Topics: Antineoplastic Agents; Binding, Competitive; Breast Neoplasms; Calmodulin; Cell Division; Estradiol; Estrogen Antagonists; Humans; Molecular Structure; Phenols; Pyrrolidines; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1992 |
A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effects.
Topics: Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Endocrine Glands; Estrogen Antagonists; Female; Growth Hormone; Humans; Prolactin; Pyrrolidines; Sex Hormone-Binding Globulin; Thyrotropin-Releasing Hormone | 1986 |